title: The benefits and risks of alemtuzumab in multiple sclerosis.
authors: Daniel
authors: D
authors: Ontaneda
authors: Jeffrey A
authors: JA
authors: Cohen
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab